Literature DB >> 32140192

Rosai-Dorfman disease with paravertebral and epidural thoracic spine involvement: A case report and literature review.

Abhilash Jayaram1, Nasser Jassim Al Maslamani1, Nazeer Ahamad Puthiyaveetil Abdul Rahiman1, Vidya Chander Negi1.   

Abstract

Rosai-Dorfman disease (RDD) with spinal cord involvement is a rare clinical entity. We report a case of RDD with paravertebral and intraspinal epidural involvement in a 24-year-old male Bangladeshi patient who presented with progressive bilateral lower limb weakness for 20 days duration associated with spasticity and muscle spasm. MRI demonstrated an enhancing paravertebral soft tissue lesion extending from C7 through T4 with intraspinal epidural extension encasing the spinal cord with focal cord oedema. Histopathology of the paraspinal-epidural lesion reported a finding consistent with RDD. The patient was initiated on high-dose steroids. Follow up after 2 months demonstrated symptomatic improvement as the patient was able to move on the crutch and repeated MRI showed lesion regression.
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Lymphoma; Rosai–Dorfman disease; Spinal cord; Tuberculosis

Year:  2020        PMID: 32140192      PMCID: PMC7044493          DOI: 10.1016/j.radcr.2020.01.026

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Rosai and Dorfman in 1969 described Rosai-Dorfman disease (RDD), a rare histiocytic disorder as a separate entity under the term sinus histiocytosis with massive lymphadenopathy (SHML) [1]. Subsequently, RDD is described as a benign, idiopathic and proliferative disease of phagocytic histiocytes mainly affecting children and young adults. There are conflicting data regarding gender and race preponderance. RDD is characterized by massive, painless, bilateral and symmetrical cervical lymphadenopathy, fever, leukocytosis, and high sedimentation rate. Other lymph nodes such as inguinal, axillary, mediastinal and upper paraaortic lymph nodes may also be involved [2]. Extra-nodal disease that frequently affects the respiratory tract, paranasal sinuses, visceral organs, skin, bones, breast, genitourinary tract, and orbits has been documented in 43% of cases [3]. The involvement of the central nervous system (CNS) in RDD is uncommon and cerebral convexities, parasagittal, suprasellar, cavernous sinuses and petroclival regions are the most frequently involved locations [4]. Isolated Rosai-Dorfman spinal cord disease is extremely rare, with only a few cases reported in the literature [5], [6], [7], [8]. We hereby report a case of Rosai-Dorfman spinal cord disease in a 24-year-old Bangladeshi man. The main purpose of this case report is to provide health care professionals with the scientific framework to gain a better understanding of the tumor biology, clinical features, pathology, and treatment for RDD.

Case presentation

24-year-old male Bangladeshi patient presented with progressive bilateral lower limb weakness for 20 days duration associated with spasticity. On physical examination, there was bilateral weakness of the lower extremities (more on the left side) associated with spasticity. The bilateral dorsiflexion power at both ankles was grade II and plantar flexion was grade IV. The power of bilateral external hallucis was grade IV. Flexion and hip extension power of right lower limb was grade IV, while on the left side it was grade II. On both knees, the extension was grade IV. The sensory level was just below the nipple at the T5 level. An initial CT scan of thoracic spine was performed, which was reported as noncontributory. Therefore, an emergency MRI of cervicothoracic spine and brain was performed to rule out demyelination, which showed paravertebral soft tissue with intraspinal epidural extension encasing the spinal cord with focal cord edema, see Fig. 1 (A, B, C, D, E, and F). A retrospective analysis of CT scan showed Focal cortical destruction of right posterolateral aspect of T2 vertebra. Paravertebral and epidural soft tissue lesion was iso to hyperdense compared with the muscle, see Fig. 2 (A and B).
Fig. 1

A. Axial T2 and B. axial T1, show paravertebral lesion with epidural extension which is isointense to spinal cord on T1 and iso to hypointense on T2 extending from C7 through T4 (white arrows). C and D: Post contrast T1 demonstrated and enhancing paravertebral soft tissue lesion with intraspinal epidural extension encasing the spinal cord. Focal cord edema and enhancement noted as well (white arrows). E. Sagittal DWI and F. ADC: The paravertebral lesion was heterogeneously bright on DWI and dark on ADC with an eccentric foci of increased signal intensity (white arrows).

Fig. 2

G and H: CT thoracic spine in bone and soft tissue window, show a focal cortical destruction of right posterolateral aspect of T2 vertebra (black arrow) and paravertebral and epidural soft tissue lesion was iso to hyperdense compared with the muscle (white arrows).

A. Axial T2 and B. axial T1, show paravertebral lesion with epidural extension which is isointense to spinal cord on T1 and iso to hypointense on T2 extending from C7 through T4 (white arrows). C and D: Post contrast T1 demonstrated and enhancing paravertebral soft tissue lesion with intraspinal epidural extension encasing the spinal cord. Focal cord edema and enhancement noted as well (white arrows). E. Sagittal DWI and F. ADC: The paravertebral lesion was heterogeneously bright on DWI and dark on ADC with an eccentric foci of increased signal intensity (white arrows). G and H: CT thoracic spine in bone and soft tissue window, show a focal cortical destruction of right posterolateral aspect of T2 vertebra (black arrow) and paravertebral and epidural soft tissue lesion was iso to hyperdense compared with the muscle (white arrows). Considering the MRI and CT findings a possibility of an infectious etiology possibly tuberculosis and lymphoma were considered in the differential diagnosis. Patient was admitted by the neurosurgery team and underwent T1-T2 Laminoplasty and excision of epidural mass. Histopathology of the paraspinal-epidural lesion reported a finding consistent with RDD. Neuro-oncology multidisciplinary team meeting advised PET-CT and referral to hematology team. PET/CT shows paravertebral moderate uptake Fig. 3. The patient was initiated on high-dose steroid. At hematology clinic the patient's cell blood count, peripheral smear and lumbar puncture were normal. Bone marrow biopsy was hypocellular with histiocytes stuffed with intact hemopoietic cells.
Fig. 3

PET/CT shows paravertebral moderate uptake (white arrow).

PET/CT shows paravertebral moderate uptake (white arrow). Follow up after 2 months demonstrated symptomatic improvement as the patient was able to move on the crutch and repeated MRI showed lesion regression, see Fig. 4.
Fig. 4

Follow-up MRI shows significant reduction of the paravertebral and epidural component of the lesion.

Follow-up MRI shows significant reduction of the paravertebral and epidural component of the lesion.

Discussion and conclusion

Four cases of a disease were described by Rosai and Dorfman in 1969, which they called SHML. 30 additional cases were analyzed in 1972, establishing SHML as a clinico-pathologic entity [9]. The exact etiology of RDD is not yet known, but various factors are thought to cause RDD such as infectious agents (ie, herpes virus, Brucella or Klebsiella, Varicella zoster virus, Epstein-Barr virus), hematopoietic malignancies, and even a genetic predisposition due to its reported occurrence in pairs of siblings [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]. Children and young adults most commonly get affected by this disease, while there are conflicting data regarding. However, male population and most commonly the individuals of African descent are more commonly affected. Clinically this disease is characterized by painless, bilateral massive cervical lymphadenopathy frequently accompanied by various symptoms such as tonsillitis, malaise, night sweats, fever, weight loss, rhinorrhea, and hepatosplenomegaly, which are nonspecific making the diagnosis difficult [1,9,12,13,20]. Extranodal involvement have some documented sites including bone, skin, genitourinary system, respiratory tract, oral cavity, eyes/orbit/ocular adnexa, CNS, tonsil, breast, salivary gland, soft tissue, and heart. In 1 study, multiple lymph node swellings of various sites involved were observed in RDD patient [21]. According to this study, low-grade fever is usually present along with hyperglobulinemia, elevated ESR, normochromic normocytic anemia and leukocytosis, which are nonspecific clinical findings and the patient's response was good to high doses of steroids [9]. In our case, there was no associated fever, nor was there any associated anemia, elevated ESR, leucocytosis, or hyperglobulinaemia while there was bilateral lower limb weakness and spasticity; left-sided weakness was more than right associated with spasticity. Radiological manifestation of Rosai-Dorfman disease can be extremely variable due to magnitude of organ systems which can be involved. Most common imaging finding on conventional and cross-sectional imaging is lymphadenopathy. Most common group of lymph nodes involved are the cervical nodes. Intracranial and spinal involvement in Rosai-Dorfman disease is uncommon. In the central nervous system, the disease may manifest as meningeal-based masses which appears as hyperattenuating on CT due to high cellular content. On MRI the lesion appears isointense to spinal cord on T1, iso to hypointense on T2 with homogenous avid postcontrast enhancement. T2 hypointensity related to high cellular content can suggest the diagnosis of RDD. In the spine the disease may manifest as epidural or intradural extramedullary mass. The lesion often shows increased uptake with gallium scan and increased metabolic uptake with FDG-PET. Rosai-Dorfman disease confined to the epidural thoracic spine is extremely rare [4], [5], [6], [7], [8],22]. Constitutional symptoms are notably absent in patients with CNS RDD [23]. Similarly, our case showed no constitutional symptoms. While CT was not performed or not documented in the case reports of isolated spinal RDD before, this patient had vertebral body erosion and paravertebral lesion which made us to think of an infectious etiology. Many of the authors reported heterogenous signal intensity on DWI and increased signal intensity on apparent diffusion coefficient (ADC) mapping which was almost keeping with this patient. Differential diagnoses of isolated spinal RDD include tuberculosis, lymphoma and meningioma. In tuberculosis there is endplate and disc destruction with paravertebral collection which usually show restriction on ADC. Lymphomas are isointense on T1 and iso to hyperintense on T2 with avid post contrast enhancement. Hypercellular lymphomas can be hypointense on T2 similar to RDD. Majority of the meningiomas are intradural rather than epidural [24]. Meningiomas are isointense on T1, iso to hyperintense on T2 with avid post contrast enhancement. The diagnosis of RDD is a challenge, a thorough radiological review and a high degree of suspicion are necessary to diagnose this rare clinical entity. Some of the patients may experience spontaneous resolution, while others may require steroid therapy or surgical resection alone or in conjunction with chemotherapy or radiotherapy. In conclusion, spinal cord involvement in DDR is a rare clinical entity that mimics lymphoma and tuberculosis. The diagnosis is challenging and needs high index of suspicious. In proper clinical setting T2 hypointensity and avid homogenous post contrast enhancement can suggest the diagnosis of RDD.
  22 in total

1.  Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin.

Authors:  Lih-Yuan Chang; Tseng-tong Kuo; Heng-Leong Chan
Journal:  Int J Dermatol       Date:  2002-12       Impact factor: 2.736

2.  Rosai Dorfman disease--a clinico-pathological presentation.

Authors:  S Mehrotra; S Ather; P Gupta; B Mehrotra
Journal:  J Assoc Physicians India       Date:  2007-08

3.  Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases.

Authors:  J Rosai; R F Dorfman
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

4.  Sinus histiocytosis with massive lymphadenopathy: fifteen new cases.

Authors:  F Lampert; K Lennert
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

5.  Isolated extranodal sinus histiocytosis presenting as an intramedullary spinal cord tumor with paraplegia. Case report.

Authors:  R K Osenbach
Journal:  J Neurosurg       Date:  1996-10       Impact factor: 5.115

Review 6.  Sinus histiocytosis with massive lymphadenopathy (Destombes-Rosai-Dorfman syndrome) occurring as a single enlarged submandibular lymph node: a light and immunohistochemical study with review of the literature.

Authors:  E Baden; P Caverivière; S Carbonnel
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-09

Review 7.  Cervical extradural meningioma: case report and literature review.

Authors:  Brian L Frank; James S Harrop; Amgad Hanna; John Ratliff
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

8.  Sinus histiocytosis with massive lymphadenopathy.

Authors:  E Foucar; J Rosai; R F Dorfman
Journal:  Arch Otolaryngol       Date:  1978-12

9.  Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy.

Authors:  E Foucar; J Rosai; R F Dorfman; J M Eyman
Journal:  Am J Clin Pathol       Date:  1984-11       Impact factor: 2.493

10.  Intracranial rosai-dorfman disease.

Authors:  Yadav Arun Kumar; Peng Yi Peng; Xia Chen Chen
Journal:  Case Rep Radiol       Date:  2014-02-11
View more
  1 in total

1.  Rosai-Dorfman disease mimicking images of meningiomas: Two case reports and literature review.

Authors:  Rafael Trindade Tatit; Paulo Eduardo Albuquerque Zito Raffa; Giovana Cassia de Almeida Motta; André Alexandre Bocchi; Júlia Loripe Guimaraes; Paulo Roberto Franceschini; Paulo Henrique Pires de Aguiar
Journal:  Surg Neurol Int       Date:  2021-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.